Hazardous Waste Management in Pharmacy Settings
This paper examines the regulatory landscape surrounding hazardous waste generated by pharmacies and other pharmaceutical supply chain participants. It traces the evolution of oversight from OSHA's occupational safety guidelines to the EPA's proposed rules targeting environmental protection, particularly the prohibition on flushing hazardous drugs such as chemotherapy agents and powerful opioids into the water system. The paper also clarifies the distinction between hazardous materials and hazardous wastes, outlines how the EPA categorizes pharmaceutical waste, and discusses the practical implications for pharmacies required to adopt compliant disposal methods under the new federal framework.
- Introduction: Overview of hazardous pharmaceutical waste and existing OSHA rules
- Current Regulations: OSHA occupational guidelines and gaps in environmental research
- The EPA Proposed Rule: EPA rule prohibiting flushing of hazardous pharmaceutical waste
- Impact on Pharmacies: Compliance costs and new disposal requirements for pharmacies
- Hazardous Waste vs. Hazardous Material: Definitional distinction and EPA waste classification categories
- Conclusion: Summary of environmental rationale behind new EPA disposal rules
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Clearly distinguishes between two overlapping regulatory frameworks — OSHA's occupational focus and the EPA's environmental focus — showing how each addresses a different dimension of the same problem.
- Uses a concrete statistic (6,400 tons of hazardous pharmaceuticals flushed annually) to establish the real-world stakes of the proposed EPA rule.
- Draws a precise conceptual distinction between "hazardous material" and "hazardous waste," grounding the policy discussion in definitional clarity.
Key academic technique demonstrated
The paper demonstrates regulatory analysis by tracing how a policy gap — occupational rules that left environmental risks unaddressed — prompted new federal rulemaking. It situates the EPA proposal within a timeline of prior OSHA guidelines and a 2008 proposed rule, showing how regulations evolve incrementally in response to identified shortcomings.
Structure breakdown
The paper opens with background on pharmaceutical hazardous waste, then surveys existing OSHA-based regulations and the limited research on environmental hazards. It next presents the EPA's proposed rule, examines its specific impact on pharmacies, clarifies the hazardous material/waste distinction, and closes with a brief conclusion tying the environmental rationale back to the new regulatory requirements. The structure moves logically from problem identification through regulatory response to practical implications.
Introduction
The pharmaceutical industry generates waste that is considered hazardous. Some of this waste takes the form of drugs that are inherently dangerous. Until recently, most regulations surrounding the handling of these drugs came from OSHA, and as such they pertained to occupational safety rather than environmental safety. OSHA has maintained recommendations for the safe handling of dangerous drugs for at least thirty years. Most hazardous drugs are cytotoxic, but others are also potentially harmful, among them drugs used in chemotherapy (Polovich, 2004).
Current Regulations
The current federal regulations come from OSHA and are designed to protect the people who either produce or dispense pharmaceuticals that fall into the hazardous category (Connor & McDiarmid, 2006). Chemotherapy agents, for example, have been linked to secondary leukemia and other cancers (Polovich, 2004). When OSHA introduced its guidelines, however, this also reduced concern within the industry about the broader hazards these drugs present. The few studies that existed were conducted from a workplace point of view, such as measuring the amount of cyclophosphamide found in pharmacies during environmental testing (Polovich, 2004).
Studies on the environmental hazards presented by medical waste tend to focus on issues other than drugs, and are usually centered on developing nations where standards for the disposal of such wastes are inchoate. In the developing world, identified issues included ordinary citizens gaining access to medical waste — including exposure to hazardous drugs — because of poor disposal practices. The risks, then, were not elaborated in the context of pharmacy workers or the broader environment, but only in relation to people who happened to be in proximity to improperly discarded waste (Patwary, O'Hare & Sarker, 2011).
The EPA Proposed Rule
The EPA has proposed rules that will govern the disposal of hazardous pharmaceutical wastes, typically meaning chemotherapy drugs or powerful opioids. The rule will affect producers, pharmacies, and reverse distributors — essentially any organization or individual involved in the supply chain or reverse supply chain for these hazardous drugs. The rule is aimed at ensuring environmental safety, particularly with respect to water quality, by prohibiting agencies from flushing hazardous wastes down the toilet. According to the EPA, 6,400 tons per year of such wastes are flushed through the sewer system (EPA.gov, 2015). The rule will affect both pharmacies and any health care provider that handles such drugs, effectively prohibiting the disposal of hazardous pharmaceuticals in this manner.
Conclusion
The new EPA rules on the disposal of hazardous drugs are designed to curtail the practice of disposing of drugs down the toilet or sink. The guidelines that had been in place prior to this rule were focused on occupational health and safety. The new guidelines, by contrast, are directed at environmental protection. They will require pharmacies that are not currently disposing of drugs correctly to begin doing so, treating hazardous drugs — such as those used in chemotherapy — as hazardous medical wastes subject to proper disposal procedures.
References
Connor, T. & McDiarmid, M. (2006). Preventing occupational exposures to antineoplastic drugs in health care settings. CA: A Cancer Journal for Clinicians, 56(6), 345–365.
EPA.gov (2015). Proposed rule: Management standards for hazardous waste pharmaceuticals. Environmental Protection Agency. Retrieved April 8, 2016.
Patwary, M., O'Hare, W. & Sarker, M. (2011). Assessment of occupational and environmental safety associated with medical waste disposal in developing countries: A qualitative approach. Safety Science, 49(8–9), 1200–1207.
Polovich, M. (2004). Safe handling of hazardous drugs. Online Journal of Issues in Nursing. Retrieved April 8, 2016 from http://www.nursingworld.org/mainmenucategories/anamarketplace/anaperiodicals/ojin/tableofcontents/volume92004/no3sept04/hazardousdrugs.html
Already a member? Log in
Unlock the rest of this paper
135,000+ research papers · AI writing tools · Plagiarism & AI detection
24-Hour Pass
Does not renew
Get 24-Hour PassMonthly
Renews at $12.99/month until canceled
Start MonthlyAnnual
Renews at $99/year until canceled
Start Annual- Unlimited AI writing tools
- Plagiarism and AI text detection tool
Plan details
Unlimited AI writing tools are for individual, non-automated use and are subject to our Terms of Service and abuse-prevention measures.
TextChecker scans: 1 during the 24-Hour Pass, or 5 per month with Monthly and Annual.
Prices exclude applicable tax.
Always verify citation format against your institution’s current style guide requirements.